Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$0.46.

  • Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) fell 18.18% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.24, marking a year-over-year increase of 68.83%. This contributed to the annual value of -$0.46 for FY2024, which is 4.55% down from last year.
  • Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$0.46 in FY2024, which was down 4.55% from -$0.44 recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of -$0.37 in FY2021 and a low of -$0.46 during FY2024.
  • In the last 3 years, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.44 in 2023 and averaged -$0.43.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first grew by 28.33% in 2020, then decreased by 15.79% in 2023.
  • Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$0.43 in 2020, then rose by 13.95% to -$0.37 in 2021, then declined by 2.70% to -$0.38 in 2022, then decreased by 15.79% to -$0.44 in 2023, then dropped by 4.55% to -$0.46 in 2024.